Pioglitazone increases VEGFR3 expression and promotes activation of M2 macrophages via the peroxisome proliferator-activated receptor γ

The peroxisome proliferator-activated receptor γ (PPARγ) agonist pioglitazone has been widely used in previous studies to ameliorate diabetes mellitus and regulate inflammation. However, the present study aimed to investigate the effect of pioglitazone on macrophages and determine its impact on rena...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Conghui, Zhang, Ying, Zhang, Chunxiu, Liu, Yang, Liu, Yanyan, Xu, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423577/
https://www.ncbi.nlm.nih.gov/pubmed/30816473
http://dx.doi.org/10.3892/mmr.2019.9945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423577/
https://www.ncbi.nlm.nih.gov/pubmed/30816473
http://dx.doi.org/10.3892/mmr.2019.9945

Ejemplares similares